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Mice that  express the X-linked CBA/N  genetic defect lack a  subpopulation of B 
cells that  appears  late in normal  murine  B  cell ontogeny and  that  expresses on  its 
surface  Lyb3,  Lyb5,  and  possibly Lyb7  B  cell determinants  (1-3).  These  mice are 
functionally abnormal in that as adults they display an immune response pattern to 
virtually all classes of antigens normally characteristic of neonatal  mice  (4,  5).  The 
most  profoundly  affected  immune  responses  in  adult  CBA/N  mice  are  those  to 
thymic-independent type-2 (TI-2) t antigens such as trinitrophenyl (TNP)-conjugated 
Ficoll (TNP-FicoI1) and pneumococcal polysaccharide, which are entirely absent  (6, 
7),  except  perhaps  in  very  old  mice  (8).  Less  affected,  but  still considered  to  be 
abnormal, are responses to thymic-independent type-1  (TI-1) antigens such as TNP- 
lipopolysaccharide (LPS) and TNP-Brucella abortus (BA) (9,  10). In contrast, the effect, 
if any, of the CBA/N  genetic defect on responses to thymic-dependent (TD) antigens 
such  as TNP-keyhole limpet hemocyanin  (KLH)  and sheep erythrocytes (SRBC)  is 
controversial  (2,  11,  12).  One  explanation  for abnormal  immune  responsiveness in 
adult  CBA/N  mice  is  that  those  B  cells these  mice  do  possess  are  not  themselves 
abnormal, but, rather, that CBA/N  mice lack that B cell subpopulation characterized 
by the expression of the Lyb5 determinant  that  is present in normal mice and that 
responds to all classes of antigens. 
Left unexplained by this hypothesis is the failure of the B  cells that adult CBA/N 
mice do possess to respond to TI-2 antigens, low doses of TI-1 antigens, and possibly 
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to low doses of TD antigens. Because most antibody responses, especially those to TD 
antigens, result from the activation of B cells by their interaction with the products of 
helper T  cells and/or antigen-presenting accessory cells, rather than from the activa- 
tion  of B  cells  by  antigen  alone,  it  seemed  possible  that  the  abnormal  response 
phenotype of CBA/N mice might be the result of a nonproductive cellular interaction 
between CBA/N B cells and another required cell type. Indeed, it has recently been 
observed  that  in  normal  B  cell  populations  depleted  of Lyb5  + cells,  the remaining 
Lyb5-  B  cells  failed  to  be  activated  by  their  interaction  with  antigen-presenting 
accessory cells (13). 
To  determine  the  cellular  basis  for  the  abnormal  primary  immune  responses 
observed  in CBA/N  mice,  the  present  report  has assessed  the ability of each of the 
interacting cell subpopulations from these mice to function in TD responses to TNP- 
KLH as well as in thymic-independent responses to TNP-FicolI, TNP-LPS, and TNP- 
BA. The results of these experiments suggest that the abnormal responses observed in 
mice that express the CBA/N genetic defect could be the consequence of a single cell 
interaction defect between antigen-presenting accessory cells and B cells. 
Materials  and Methods 
Animals.  FI mice derived  from crosses  between  DBA/2 and CBA/N mice were obtained 
from the small  animal section,  National  Institutes  of Health,  Bethesda,  Md.,  or from Flow 
Laboratories, Inc., Rockville, Md. Because the immune defect of CBA/N mice is X-linked, F1 
male  offspring  from  crosses  between  CBA/N  ~  and  DBA/2  ~3,  (CBA/N  ×  CBA/2)F1  c~ 
(CBD2FI),  are  hemizygous for the  defective gene xid  and  are immunologically abnormal, 
whereas the F1 male offspring from crosses between DBA/2 9 and CBA/N C~, (DBA/2 × CBA/ 
N)F1 d  (D2CBFI), are immunologically normal. All mice were used at 6-12 wk of age, unless 
otherwise stated. 
Antigens.  Aminoethylcarboxymethyl70FicoU  (aecm-Ficoll)  was  obtained  from  Biosearch 
Labs, San  Rafael, Calif.;  KLH (lot  530195)  was obtained from Calbiochem Behring Corp., 
American Hoechst, San Diego, Calif.; LPS was obtained from the phenol extract of Salmonella 
minnesota R595 hexose-less  mutant and was a gift from Dr. John Ryan, Yale University, New 
Haven, Conn.; BA was obtained from the U. S. Department of Agriculture, Ames, Iowa. All 
four  antigens  were  conjugated  with  2,4,6-trinitrobenzene  sulfonate  (Pierce  Chemical  Co., 
Rockford, I11.) as previously described  (13,  14)  to yield TNP-Ficoll (28 TNP groups/400,000 
dalton aecm-Ficoll), TNP-KLH (20  groups/100,000 dalton KLH), TNP-LPS, and TNP-BA. 
Fresh SRBC were obtained weekly from a single sheep, No.  1245. 
In Vivo Immunization.  In those experiments in which in vivo primary responses were assayed, 
mice were immunized intravenously with antigen in saline on day 0 and assayed for the number 
of TNP-specific plaque-forming cells (PFC) in their spleens on day 4. In vivo responses to TNP- 
KLH over the antigen dose-response range examined were shown to be T  cell  dependent  in 
adoptive transfer experiments (data not shown). 
Preparation of Cell Populations 
DEPLETION OF r  CELLS.  Spleen cells were depleted of T  cells to yield (B +  accessory)  cell 
populations by pretreatment  with a rabbit  anti-mouse brain serum  (RAMB)  +  complement 
(C'). The specificity of the RAMB reagent employed has been described previously and, under 
the treatment conditions used, is specifically cytotoxic for T  cells (15). 
DEPLETION  OF ADHERENT  ACCESSORY  CELLS.  Spleen cells were depleted of adherent accessory 
cells to yield (T +  B) cell  populations by passage over G-10 Sephadex  (lot  5164,  Pharmacia 
Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) as previously described (15). Viable 
cell  recovery  after  G-10  Sephadex  passage  ranged  between  50  and  60%. Such  treatment 
significantly  reduces  the  number  of phagocytic cells  but  does  not  significantly  affect  the 
percentage of T  or B cells (16). 
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nonadherent etuate collected. Such nylon nonadherent spleen-cell populations are markedly 
depleted of surface immunoglobulin positive (slg  +)  cells and enriched in theta-bearing cells 
(15). 
PREPA~,TION  OF SPLEEN ADnEBENT  CELLS.  Glass-adherent spleen cells (SAC) were prepared 
as previously described (15). All SAC populations were irradiated with 1,000 rad, in most cases 
after prior treatment with RAMB + C', and precultured at 10  r cells/ml overnight on a rotating 
drum at 37°C before addition to the antibody cultures. Such populations have been character- 
ized and consist of 50-80% latex-ingesting  cells, 8-15% nonphagocytic surface Ig  + cells, <0.3% 
Thy 1.2  + cells, and 15-25% cells negative for these markers (16). The accessory cell activity of 
the SAC population in antibody responses has previously been shown to reside in a non-T, non- 
B, glass adherent, radiation-resistant, Ia  +, phagocytic cell that probably can be considered a 
macrophage or macrophage-like cell (17, 18). 
PULSING OF SAC WITH SOLUBLE ANTIGENS.  SAC were prepared as above except that they were 
precultured overnight in the presence of TNP-Ficoll (1 #g/ml) or TNP-KLH (100 #g/ml). At 
the end of the overnight preculture, the pulsed SAC were washed at  least  three times and 
resuspended for  addition to  the antibody cultures. To control for  the  possibility of soluble 
antigen carry-over in the pulsed SAC suspensions, supernates from the final SAC were always 
assayed for the presence of soluble antigen by its ability to stimulate responses  in competent 
spleen cell populations. 
PULSING OF SAC WITH  TNP-BA.  SAC were prepared as above except that they were precultured 
overnight in the presence of ~ 10  9 TNP-BA organisms/ml. Because TNP-BA organisms are in 
suspension and not in solution, an additional control to that of assaying the final SAC wash for 
antigen was performed. To control for the possibility that free TNP-BA organisms not associated 
with SAC had pelleted to the bottom of the tube during the SAC washes, a mock pulsing was 
performed in parallel by culturing an equivalent amount of TNP-BA in a tube that contained 
no SAC. At the end of the overnight preculture, both the pulsed SAC and the control were 
washed at least three times and resuspended for addition to the antibody cultures. 
CULTURE CONDITIONS.  0.5-1  ×  10  ~ unprimed responding spleen  cells  were  placed  into 
culture in a  medium that contained 5 ×  10  -5 M  2-mercaptoethanol in 0.2-ml final vol flat- 
bottomed microtiter plates for 4 d at 37°C in a 5% CO2-humidified air atmosphere as previously 
described (14). Unless otherwise stated, antigens were added so that their final concentrations 
in culture were:  TNP-KLH,  5  /~g/ml;  TNP-FicolI,  10  -~ /~g/ml;  TNP-BA, 0.05%  of stock 
suspension that  contained ~10  Ix organisms/ml; TNP-LPS, 2 /xg/ml;  SRBC,  0.01%  vol:vol. 
Exclusive of the use of TNP-LPS that induced proliferation, viable cell recovery was independ- 
ent of the presence or absence of antigen. 
There was also no difference in the viable cell recovery of abnormal CBD2F1 spleen cells and 
normal D2CBFI spleen cells. 
PFc ASSAY.  SRBC were conjugated with TNP (TNP-SRBC) by the method of Rittenberg 
and Pratt (19). Direct (IgM) PFC to TNP-SRBC and unmodified SRBC were assayed by the 
slide modification of the Jerne hemolytic plaque technique (20). Anti-TNP PFC responses have 
been shown to be TNP-specifie by two criteria:  (a)  >90%  inhibition by 5 ×  10  -5 M  TNP- 
bovine serum albumin (14, 15), and (b)  the absence of virtually any PFC on unhaptenated 
SRBC (Unpublished results.). 
Results 
In  Vivo Primary Anti-TNP PFC Responses to  TNP-FicoU  and  TNP-KLH in  Mice  that 
Express  the  CBA/N Immune  Defect.  The  in  vivo  responses  of unprimed abnormal 
CBD2F1  male  mice  to  optimal  doses  of  soluble  TNP-Ficoll or  TNP-KLH  were 
compared with those of their normal reciprocal F1 male counterparts (D2CBFI). As 
expected,  normal  D2CBFI  mice  responded  to  both  antigens,  whereas  abnormal 
CBD2F1 mice responded only to TNP-KLH  (Table I). The lower response observed 
in abnormal F~ mice to TNP-KLH was consistent with their having approximately 
one-half the  number of spleen  B  cells  of  their  normal  counterparts  as  has  been 
suggested (11, 21). Indeed, the in vivo responses of abnormal CBD2F1 male mice to H.  S.  BOSWELL,  M.  I.  NERENBERG,  I.  SCHER, AND A. SINGER 
TABLE I 
In  Vivo Pa'ma~y IgM PFC Responses to Soluble TNP-Fi¢oll and TNP-KLH 
1197 
Strain  TNP-KLH*  TNP-Ficoll~  No antigen 
PFC/ IO  e spleen cells§ 
Abnormal CBD2F~ c~  327 (1.23)  3 (1.48)  3 (1.41) 
Normal D2CBF1 d  861 (1.18)  >1,000  17 (1.02) 
* 100 #g intravenous. 
:~ 50 gg intravenous. 
§ Geometric mean with SE in parentheses of responses from at least three individual mice assayed 4 d after 
intravenous immunization. 
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FIc.  1.  Comparison of the in vivo primary immune responses to soluble TNP-KLH of normal and 
abnormal F~ male mice. Normal  D2CBF1 male mice (O) and abnormal CBD2FI male mice (A) 
were immunized intravenously with graded doses of TNP-KLH in saline. Primary IgM anti-TNP 
PFC responses were measured 4 d after immunization.  Each point represents the geometric mean 
of the responses of three to five mice. 
TNP-KLH  was consistently approximately one-half those of their reciprocal normal 
F1 counterparts to high doses (25-100 #g) of TNP-KLH  (Fig.  I). However, this ratio 
of responsiveness did not hold at lower doses of antigen because normal D2CBFa mice 
generated  detectable responses even  at  the lowest dose  (1  #g)  of TNP-KLH  tested, 
whereas abnormal CBD2F1 mice did not respond to even  10 times that amount  (Fig. 
1). These results suggest  that, whereas  differences in number  of B  cells might  be a 
sufficient explanation for the lower responses of abnormal mice to high doses of TNP- 
KLH, it is not a  satisfactory explanation for the failure of abnormal mice to generate 
any response to low doses of TNP-KLH.  Rather, they suggest the possibility that the 
cellular interactions stimulated by low doses of TNP-KLH  might  be insufficient to 
trigger the  B  cell populations in  abnormal  mice, even  though  they are apparently 
sufficient to activate the B  cell populations in normal mice. 
In  Vitro Analysis of the Ability of Abnormal CBD2F1 Male Spleen Cells to Generate Prima~y 1198  ACCESSORY  CELL-B  CELL  INTERACTION  DEFECT  IN  CBA/N  MICE 
Responses  to TNP-KLH.  To further examine the possibility that the cellular activation 
requirements of B cells from abnormal F1 mice might differ from those from normal 
F1  mice  for  the  helper  T  cell-dependent  response  to  TNP-KLH,  the  ability  of 
unprimed spleen cells from these mice to generate primary PFC responses was assessed 
in  vitro.  As  noted  in  earlier  reports,  spleen  cells  derived  from  abnormal  F1  mice 
responded in vitro to optimal concentrations of the T cell-independent antigens TNP- 
LPS and TNP-BA, but were absolutely unresponsive to optimal concentrations of the 
T  cell-independent  antigen  TNP-Ficoll  (Table  II,  experiment  I).  However, quite 
unexpected was the profound failure of spleen cells from abnormal FI mice to generate 
any  primary  helper  T  cell-dependent  response  in  vitro  to  TNP-KLH  (Table  II, 
experiment 1). In fact, spleen cells from abnormal F1 mice were unable to generate in 
vitro responses to even 50 times the amount of TNP-KLH immunogenic for spleen 
cells from normal Fa mice (Table II, experiment 2).  Identical results were observed 
with spleen cells from abnormal CBD2F1 mice that ranged in age from 2-5 mo, even 
though under the primary culture conditions used:  (a) spleen cell populations from 
normal mice were competent to respond to TNP-KLH, (b) spleen cell populations 
from abnormal  F1 mice generated anti-TNP responses to TNP-LPS and TNP-BA, 
and (c) the viable cell recovery of cells from unresponsive abnormal CBD2F1 cultures 
were equivalent to those from unstimulated  normal  D2CBF1 cultures.  Because the 
spleen cells from these mice were also unable to generate T  cell-dependent responses 
under these culture conditions to SRBC (Table II, experiment 3), an antigen unrelated 
to  TNP-KLH,  it  can  be  concluded  that  mice  that  express  the  X-linked  CBA/N 
genetic  immune  abnormality are  profoundly deficient  in  their  ability  to  generate 
helper T  cell-dependent primary antibody responses under limiting in vitro micro- 
TABLE II 
In  Vitro Primal7 IgM PFC Responses of Normal arid Abnormal Ft Male Spleen Cells to TD and Thymic- 
independent Antigens 
Abnormal 
Experiment  Antigen  Antigen class  Normal D2CBFI ~  CBD2Ft ¢~ spleen 
spleen cells  cells 
PFC/10  e cultured cells* 
1  TNP-LPS  TI- l  264 (1.11)  366 (1.14) 
TNP-BA  TI-I  172 (1.10)  253 (1.17) 
TNP-Ficoll  TI-2  114 (1.05)  0 
TNP-KLH  TD  154 (1.10)  6 (2.71) 
No antigen  3 (1.82)  0 
TNP-KLH  1/zg/ml  86 (1.19)  3 (1.76) 
5 #g/ml  276 (1.40)  2 (1.54) 
10/~g/ml  392 (1.04)  4 (1.16) 
25/Lg/ml  250 (1.18)  5 (1.10) 
50 #g/ml  242 (1.09)  5 (1.27) 
No antigen  3 (2.05)  2 (1.49) 
TNP-LPS  TI-I  386 (1.07)  332 (1.31) 
TNP-KLH  TD  330 (1. l 1)  0 
SRBC  TD  107 (1.25)  2 (1.60) 
No antigen  2 (1.25)  2 (1.25) 
* Geometric mean with SE in parentheses of triplicate cultures. H.  S.  BOSWELL,  M.  I.  NERENBERG,  I.  SCHER,  AND A.  SINGER  1199 
culture  conditions.  An  understanding  of the  cellular  basis  of this  genetic  defect 
requires that  the cell subpopulation(s)  be identified in which  the genetic defect is 
expressed. 
Assessment  of Helper  T  Cell  Function and Antigen-presenting  Accessory Cell  Function for 
Responses to  TNP-KLH in Abnormal CBD2Ft Spleen Cell Populations.  The ability of T 
cells from abnormal  Fz mice to provide helper function for responses to TNP-KLH 
was assessed by the addition of graded numbers of spleen T  cells from either normal 
or abnormal Fz mice to cultures that had been depleted of T  ceils by treatment with 
RAMB  +  C'  (Fig.  2).  T  cells derived from abnormal  spleen cell populations were 
essentially as competent as those from normal spleen cell populations in providing 
help to T  cell-depleted populations derived from normal D2CBF1 mice (Fig. 2 A). In 
contrast,  neither  helper  T  cell  population  was  able  to  stimulate  T  cell-depleted 
populations from abnormal  Fa mice to respond to TNP-KLH (Fig.  2 B). Thus, the 
unresponsiveness of abnormal CBD2F1 spleen cells to TNP-KLH was not the result 
of defective helper T  cell function, but rather the result of a  defect in the ability of 
their non-T cell population to function in responses to TNP-KLH. 
To determine whether the failure ofCBD2F1 T cell-depleted populations to function 
in responses to TNP-KLH was the result of the inability of the accessory cells in these 
populations to present TNP-KLH, SAC from both normal and abnormal F1 spleens 
were prepared as accessory cell populations, pulsed overnight with TNP-KLH, and 
assayed for their ability to function as TNP-KLH-presenting cells.  Graded numbers 
of these antigen-presenting cells were added  to cultures of spleen cells depleted of 
adherent accessory cells by G-10 Sephadex passage (Fig. 3). SAC from both normal 
and abnormal Fz mice were equally competent in their ability to present TNP-KLH 
to normal F~ lymphoeytes (Fig. 3 A), demonstrating that accessory cells from abnormal 
mice were not defective in their ability to present T cell-dependent antigens. However, 
the addition of these same competent TNP-KLH-presenting accessory cell populations 
to lymphocytes from abnormal CBD2FI mice did not result in the generation of any 
response (Fig. 3 B). 
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Fro.  2.  Helper cell function of T  ceils from normal and abnormal Fz male mice for responses to 
TNP-KLH. Graded numbers ofT cells from normal D2CBFI male spleens (O) or abnormal CBD2FI 
male spleens (A) were added to cultures that contained 4  ×  10  s RAMB +  C'-treated spleen cells 
from either normal (A) or abnormal (B)  mice. Cultures were stimulated by the addition of either 
TNP-KLH  (open  figures) or medium alone  (closed  figures). No PFC were generated in cultures 
containing only T  cells and antigen. 1200  ACCESSORY CELL-B CELL INTERACTION DEFECT  IN CBA/N MICE 
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Fro,  3.  Antigen-presenting accessory cell function of SAC  from  normal and  abnormal F]  male 
mice for responses to TNP-KLH. Graded numbers of SAC from either normal D2CBF1 male mice 
(O) or abnormal CBD2F] male mice (A) that had been pulsed with TNP-KLH (open figures) or 
medium (closed figures) were added  to cultures that contained 5 X 105 G-10-passed spleen cells 
from either normal mice (A) or abnormal mice (B). 
These experiments demonstrate that the inability of abnormal CBD2F1 spleen cells 
to generate primary in vitro responses to TNP-KLH is not the result of either defective 
helper T  cell function or defective antigen-presenting accessory cell function. Rather, 
it  is  the  result  of an  inability of competent  accessory cells and competent  helper  T 
cells to activate B lymphocytes from abnormal mice to respond to TNP-KLH. 
Cellular Analysis of the CBA/N Genetic Defect in the Generation of T-independent Responses 
to  TNP-Ficoll.  Because  the  profound  failure  of abnormal  CBD2F1  spleen  cells  to 
generate helper T  cell-dependent responses in vitro to TNP-KLH did not result either 
from defective helper T  cell  function or from defective antigen-presenting  accessory 
cell function, it seemed reasonable to hypothesize that the B cell defect responsible for 
unresponsiveness to TNP-KLH  might also be responsible for the failure of abnormal 
spleen  cells  to  generate  T  cell-independent  responses  to TNP-Ficoll.  Although  the 
inability  of CBA/N  mice to respond  to TNP-Ficoll  has  generally  been  assumed  to 
derive  from a  defect  in  their  B  cell  compartment,  TNP-Ficoll  responses  do require 
accessory cells  (14),  and  the  inability  of abnormal  CBA/N  mice to generate TNP- 
Ficoll responses might be the result of defective accessory cell function for TNP-FicoU 
in  genetically  defective  mice.  This  possibility  was  examined  by  depleting  normal 
D2CBF1  spleen  cells  of adherent  accessory cells  by G-10  Sephadex  passage  (Table 
III). Such treatment  did not influence the ability of spleen cells to respond to either 
TNP-LPS  or  TNP-BA  (Table  III),  which  confirms  previous  observations  that  re- 
sponses  to these  two antigens  did  not  require  the  presence or function of adherent 
accessory cells (13). In contrast, the ability of normal D2CBFx spleen cells to respond 
to TNP-Ficoll was abrogated by G-10 passage and the attendant removal of adherent 
accessory cells  (Table  III). SAC from both normal  D2CBF1 and abnormal CBD2F1 
mice  were  equally  competent  in  reconstituting  the  ability  of G-10-passed  normal 
D2CBF1 lymphocytes to respond to TNP-FicoI1, and so were indistinguishable in their 
ability to provide accessory cell function for this response  (Table III). In addition  to 120I 
300 
Strain of 
Spleen cells  Treatment of  SAC (I  ×  TNP-Fi-  TNP-LPS  TNP-BA  No anti- 
5 ×  105/culture  spleen cells  104/cul  -  coil  gen 
lure) 
PFC/  I0 a cultured cells * 
Normal D2CBF~ d  --  --  126 (1.28)  332 (1.08)  220 (1.05)  2 (1.38) 
Normal D2CBF~  G-10 Passage  --  16 (1.38)  572 (1.29)  228 (1.07)  2 (1.52) 
Normal D2CBF~  G-10 Passage  D2CBFz  154  (1.07)  ND:I:  ND  2  (1.52) 
Normal D2CBF~  G-10 Passage  CBD2FI  182 (l.tO)  ND  ND  2 (1.(30) 
* Geometric mean with SE in parentheses of triplicate cultures. 
:~ ND, not determined. 
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TABL~  III 
Accessory Cell Function for T  Cell Independent Responses to  TNP-Ficoll 
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Fro.  4.  Antigen-presenting accessory cell  function of SAC  from normal and abnormal  F1  male 
mice for responses to TNP-Ficoll. Graded numbers of SAC from either normal D2CBFl male mice 
(O)  or abnormal CBD2F~ male mice (A) that had been pulsed with TNP-Ficoll  (open figures) or 
medium (closed figures) were added  to cultures that  contained 5  ×  10  s G-10-passed spleen cells 
from either normal mice (A) or abnormal mice (B). 
functioning  equally  well  as  TNP-Ficoll  accessory  cells,  SAC  from  both  normal 
D2CBF1 and  abnormal  CBD2Fz mice that  had  been pulsed with TNP-Ficoll were 
equally competent in functioning as TNP-Ficoll-presenting cells in triggering normal 
B cells to respond to TNP-Ficoll (Fig. 4). All the TNP-Ficoll present in these cultures 
was cell-associated because assays of the SAC washes were always negative for the 
presence of soluble TNP-Ficoll along with the pulsed SAC. In addition, the ability of 
pulsed SAC to present TNP-Ficoll to B cells was not merely a  result of their having 
trapped antigen, because it has been previously shown that TNP-Ficoll-pulsed SAC 
must be viable to function as TNP-Ficolt-presenting cells (14). However, in contrast 
to the ability of normal F]B cells to be activated by both TNP-Ficoll-presenting cell 
populations, B cells from abnormal F] mice could not be triggered by either presenting 
cell population to respond to TNP-Ficoll (Fig. 4). Thus, these findings suggest that 
expression of the CBA/N genetic defect in CBD2F] mice results in an inability, or at 
least a deficiency, in the B cells from these mice to be activated by antigen-presenting 
accessory cells. 1202  ACCESSORY  CELL-B  CELL  INTERACTION  DEFECT  IN  CBA/N  MICE 
Failure  of Abnormal  CBD2FI  B  Cells  to  Respond  to  TNP-BA  Presented by  Accessory 
Cells.  The data presented thus far demonstrate that abnormal CBD2F1 B cells are 
not activated by their interaction with either TNP-FicolI- or TNP-KLH-presenting 
accessory  cells.  However,  there  still  exist  two  alternative  explanations  for  these 
observations.  As  already suggested,  the  genetic defect might  result  in  a  triggering 
deficit  such  that  abnormal  B  cells  cannot  be  activated  by  their  interaction  with 
antigen-presenting accessory cells. Alternatively, it is possible that the genetic defect 
results in a recognition deficit such that the abnormal B cells cannot recognize certain 
antigens, and that it is only coincidental that responses to those antigens all required 
presentation by accessory cells.  This latter possibility seemed unlikely because the B 
cell  responses  examined  in  this  study  were  all  TNP  specific.  Nevertheless,  it  was 
possible that  the TNP-specific responses to the different antigens examined in  this 
study  required  recognition of carrier determinants  by B  cells,  and  that  the  TNP- 
specific B  cells  from abnormal  CBD2F1  mice were incapable of recognizing TNP- 
Ficoll or TNP-KLH but could recognize TNP-LPS and TNP-BA. Consequently, a 
carrier-recognition defect in abnormal B cells could only be ruled out by experiments 
in which the failure to trigger responses in abnormal B cells could not be the result of 
a  failure of these  B  cells to recognize the  antigen  per se.  These experiments were 
carried out using TNP-BA that, although capable of activating B cells directly in the 
absence of either T  cells  (4,  13)  or accessory cells  (13)  (Table III),  might  also  be 
capable  of activating  B  cells  when  presented  by  accessory cells.  To  observe such 
presentation of TNP-BA by accessory cells, the accessory cells were first pulsed with 
TNP-BA in the absence of responding B cells and then added to culture as antigen- 
presenting accessory cells. 
Indeed, SAC that had been pulsed with TNP-BA were capable of activating TNP- 
specific B cells from normal F1 mice (Fig. 5A,  13). These responses were caused by 
TNP-BA presented by SAC and not by free TNP-BA inadvertently transferred along 
with the pulsed SAC, because neither the supernate from the final SAC wash nor the 
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Fro.  5.  TNP-BA pulsed SAC activate B cells from only normal mice. Graded numbers of CBD2F] 
SAC that had been pulsed with TNP-BA (A) or medium (&) were added to cultures containing 5 
×  l0  s G-10-passed spleen cells from either normal mice (A)  or abnormal mice (B).  In addition, a 
mock pulsing was performed by treating TNP-BA suspension containing no SAC (r-I)  precisely as 
the pulsed SAC as a  control for the possible pelleting of free TNP-BA organisms with SAC in the 
pulsed SAC groups. The response to TNP-BA suspension added directly to culture is also indicated 
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control  TNP-BA  pellet  from  the  mock  TNP-BA  pulsing  performed  in  parallel 
contained sufficient antigen to stimulate significant responses in these same F1 B cells 
(Fig. 5 A). In contrast to the ability of B cells from normal F1 mice to be activated by 
TNP-BA-pulsed SAC,  B  cells from abnormal  F1  mice were not  activated by these 
TNP-BA-presenting accessory cells, even though these B cells were activated by TNP- 
BA free in suspension (Fig. 5 B). 
Thus, these results demonstrate that TNP-specific B cells from abnormal F1 mice 
are not responsive to antigen-presenting accessory cells, even when the antigen being 
presented was one to which these B cells could otherwise respond. These results suggest 
that  the  cellular  basis  of the  abnormal  immune  responses  observed  in  mice  that 
inherit the CBA/N genetic defect is that the B cells in these mice fail to productively 
interact with antigen-presenting accessory cells. 
Discussion 
Because the B lymphocyte population in mice that express the X-linked CBA/N 
genetic defect is either entirely devoid or extremely depleted of an Lyb5  + subpopu- 
lation, it is not surprising that B cell responses in these mice are not identical to those 
in normal mice. However, responses to all types of antigens are not equally affected 
by the absence of the Lyb5  ÷ B cell subpopulation. Indeed, expression of the CBA/N 
genetic  defect  results  in  responses  to TI-2 antigens  being entirely absent,  whereas 
responses to TI-1 antigens and TD antigens are affected less dramatically. The present 
report has approached this issue by an analysis of the responses of CBA/N mice to 
TI-I, TI-2, and TD antigens from the perspective that the response to each antigen 
class represented an independent assessment of the cellular activation requirements of 
B cell populations genetically deprived of Lyb5  ÷ cells. 
Analysis  of the  TD  response  to  TNP-KLH  revealed  that  genetically  defective 
CBD2F1 male mice can generate primary helper T  cell-dependent responses in vivo, 
but  only to  high  doses  of antigen.  The  failure of these  mice  to  generate primary 
responses to low doses of TNP-KLH in vivo was observed for all concentrations of 
TNP-KLH under in  vitro microculture conditions  in which  cell numbers and  the 
potential  number  of cellular  interactions  were  probably  limiting.  The  profound 
unresponsiveness of these mice in vitro was the result of neither incompetent helper T 
cell  function  nor  incompetent  antigen-presenting  accessory cell  function.  Indeed, 
within the limits of the in vitro assay to assess such functions, there were no discernible 
differences in the ability of the appropriate cell populations from normal or abnormal 
mice to perform as helper T cells or antigen-presenting accessory cells. Similar analysis 
of thymic-independent  responses  to  TNP-Ficoll  similarly  revealed  no  flaw  in  the 
ability of accessory cells from abnormal mice to present TNP-FicoI1. Thus, the failure 
to generate in vitro either primary TD responses to TNP-KLH or thymic-independent 
responses to TNP-Ficoll resulted from the inability of B cells from genetically defective 
mice  to  be  activated  by  their  interaction  with  competent  helper  T  cells  and/or 
competent antigen-presenting accessory cells. 
The inability of B ceils from abnormal mice to be activated by antigen-presenting 
accessory cells was not limited to accessory cell presentation of TD and TI-2 antigens, 
but included accessory cell presentation of TI-1 antigens as well. In the experiments 
presented in this report, even though abnormal B cells were triggered by TNP-BA in 
suspension, these same B cells were not triggered by TNP-BA presented by antigen- 1204  ACCESSORY CELL-B CELL INTERACTION DEFECT  IN CBA/N MICE 
pulsed accessory cells. Taken together, the results of these experiments strongly suggest 
that the B cells from genetically defective mice are not activated by their interaction 
with  antigen-presenting  accessory  cells,  regardless  of the  antigen  being  presented. 
These conclusions are consistent with and extend the recent observation that CBA/N 
B cell populations fail to physically bind and form clusters around macrophages (22). 
Because  at  least  one  nonproductive cellular  interaction  in  mice that  express  the 
CBA/N  genetic  defect  appeared  to  be  between  B  cells  and  antigen-presenting 
accessory cells,  is  it  possible  that  all  of the abnormal  response  patterns  observed  in 
CBA/N  mice  resulted  from  this  single  interaction  defect?  Indeed,  it  is  possible  to 
construct  a  cell  interaction  model  that  does  account  for  many  of  the  response 
abnormalities observed in genetically defective mice. One model of the cell interactions 
possible in normal and genetically defective mice is schematically illustrated  in Fig. 
6.  In  this  model,  only  Lyb5  ÷  B  ceils  can  be  triggered  by accessory cell  activation 
signals  (13),  and  it  is  the  Lyb5  ÷  B  cell  subpopulation  that  is  absent  in  mice  that 
express the CBA/N genetic defect  (1,  23).  The profound defect in mice that express 
the CBA/N genetic defect in response to TI-2 antigens results from the fact that TI- 
[]  NORMAL  MICE  /  Hig  h  DO~sesT~l*l 
.... TD 
r~  CBA/N MICE 
Fro.  6.  One model of the cell interactions possible in normal and abnormal  mice. This model 
presumes that the cell populations present in CBA/N mice are intrinsically normal and that the 
abnormal primary immune responses observed in CBA/N mice result entirely from the absence of 
Lyb5  + B cells and the  inability of antigen-presenting accessory cells to activate  Lyb5- B cell 
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2 antigens can only activate B cells via an accessory cell-B cell interaction pathway 
that is nonfunctional in these mice. In contrast, there exist other pathways by which 
TI-1 and TD antigens can activate B cells. Specifically, TI-1 antigens at high doses 
activate both Lyb5  + and Lyb5- B cell subpopulations directly; at low doses, however, 
these antigens behave like TI-2 antigens in that they are taken up by accessory cells 
and  subsequently presented only to Lyb5  + B  cells. TD antigen  responses are even 
more complex in that there exist several different interaction pathways by which B 
cells can be activated. For example, after the triggering of helper T  cells by antigen- 
presenting  accessory cells,  activated helper T  cells can  directly interact with  both 
Lyb5  +  and  Lyb5-  B  cell  subpopulations,  as  well  as  with  accessory cells.  Under 
conditions in which T  cell help is transmitted to B cells indirectly via accessory cells, 
the  result  is  the  activation of only Lyb5  +  B  cells,  and  it  is  under these  particular 
conditions that  B cells from abnormal mice (Lyb5-) would be unresponsive to TD 
antigens. However, under other conditions, T  cells could interact directly with B cells 
and so activate both Lyb5  + and Lyb5- cell subsets, and it is under these conditions 
that B cells from abnormal mice would be responsive to TD antigens. 
The  specific  conditions  under  which  direct  rather  than  indirect  T  cell-B  cell 
interactions would occur might reasonably be expected to be those in which a  great 
deal of T  cell help is generated (e.g., in vivo or with antigen-primed cell populations 
in vitro) because the chance encounter of a specific helper T  cell with a specific B cell 
must be infrequent. In contrast, because accessory cells are not antigen specific, they 
potentially  represent  a  more  efficient,  if indirect,  means  of transmitting  limited 
amounts of specific T  cell signals to specific B cells, as has been suggested by others 
(24). Thus, under conditions in which the number of specifically activated T  cells is 
limiting  (e.g., in  vivo with  low concentrations of antigen or in  vitro microcultures 
using unprimed cells), the T cell-accessory cell-Lyb5  ÷ B cell activation pathway would 
predominate, and it is under such conditions that abnormal mice would be unrespon- 
sive to TD antigens. 
This model of the cell interactions leading to B cell activation in both normal and 
genetically defective mice  offers several  potentially useful  insights.  (a)  The  rather 
confusing and sometimes conflicting patterns of responsiveness and unresponsiveness 
observed in mice that express the CBA/N genetic defect can be the result of a single 
nonproductive cell interaction that derives both from the absence of Lyb5  + B cells in 
these  mice  and  the  inability  of Lyb5-  B  cells  to  be  triggered  by  accessory cell 
activation signals.  (b) Because the activation of B cells by accessory cells may be the 
only defective cell interaction in these mice, the absence of a specific response in mice 
that  expresses the CBA/N  genetic defect is  suggestive evidence that  that  response 
requires an  accessory cell-B cell activation step.  (c)  Because the  responses  to TI-2 
antigens, which this model proposes as proceeding only via an accessory cell-B cell 
activation step, have been reported to be inhibited by anti-Lyb7 specific serum (3), it 
is possible that anti-Lyb7 serum blocks the interaction of B cells with accessory cells, 
possibly by interfering with reception of accessory cell activation signals by the B cell. 
(d) The feature that primarily distinguishes TD antigens from TI-2 antigens according 
to this model is the ability of TI-2 antigens  to directly stimulate accessory cells to 
activate B cells. Thus, it is possible that the structural features that characterize TI-2 
antigens result in their being able to directly activate accessory cells, rather than B 
cells.  (e) Finally, in terms of the current controversy regarding the importance of H-2- 1206  ACCESSORY  CELL-B  CELL  INTERACTION  DEFECT  IN  CBA/N  MICE 
restricted helper T  cell activation of B cells, this model proposes that activation of B 
cells in helper T  cell-dependent responses might not always occur via direct interac- 
tions  between  helper  T  cells  and  B  cells  but,  rather,  could  also  proceed  via  an 
accessory cell intermediary. In this case, it would not be surprising ifT cell recognition 
of B cell Ia determinants did not occur, as indeed has been observed in this in vitro 
primary response system (25).  In contrast, it is also possible that under conditions in 
which  direct  T  cell  B  cell  interaction  can  occur,  T  cell  recognition  of B  cell  Ia 
determinants might be required for direct activation of B cells by helper T cells. Thus, 
depending  upon  the  B  cell  activation  pathways  permitted  by  the  experimental 
conditions, one or both B cell subpopulations would be activated and H-2-restricted 
T-B interactions would or would not be observed. 
Whether or not this particular cell interaction model is correct, the present data do 
suggest that mice that express the CBA/N genetic defect are unresponsive to antigens 
that  require accessory cell presentation.  It  is suggested  that  such  unresponsiveness 
results from the absence in these mice of that B cell subpopulation (Lyb5  ÷) that can 
be  activated  by  antigen-presenting  accessory  cells.  Thus,  these  mice  are  always 
unresponsive to TI-2 antigens but fail to respond to TI- 1 and TD antigens only under 
those  experimental  conditions  that  discourage  direct  activation  of Lyb5-  B  cells. 
Finally, it should be emphasized that even though a single interaction defect between 
accessory cells and B cells is sufficient to account for many of the observed response 
abnormalities  in mice that  express the CBA/N genetic defect, these studies  do not 
preclude the possibility that other cellular interaction deficits may also exist in these 
mice. 
Summary 
The effect of the X-linked CBA/N genetic defect on the ability of mice to generate 
primary responses to thymic-dependent and thymic-independent antigens was assessed 
by comparing the ability of abnormal  (CBA/N ×  DBA/2)F1 male mice and normal 
(D8A/2  ×  CBA/N)F1  male  mice  to  generate  2,4,6-trinitrophenyl  (TNP)-specific 
plaque-forming  cell  responses  to  TNP-keyhole  limpet  hemocyanin  (KLH),  TNP- 
conjugated Ficoll (TNP-FieolI), TNP-BruceUa abortus (BA), and TNP-lipopolysaccha- 
ride (LPS). The reciprocal F1 combinations used in this study differ genetically only 
in the origin of their X  chromosome, but differ immunologically in that  (CBA/N × 
DBA/2)F1 male mice express all the CBA/N immune abnormalities, whereas (DBA/ 
2 ×  CBA/N)F1 male mice are immunologically normal. 
Analysis of thymic-dependent responses to TNP-KLH revealed that abnormal F1 
mice were capable of generating primary responses in  vivo to high  doses of TNP- 
KLH, but failed to generate responses to suboptimal doses of TNP-KLH that were 
still immunogenic for normal F1 mice. Furthermore, under limiting in vitro micro- 
culture conditions, the abnormal FI mice failed to generate primary thymic-dependent 
responses  to  any  dose  of TNP-KLH, even  though  under  the  identical  conditions 
normal  F1  mice consistently responded to a  wide antigen  dose range.  The cellular 
basis  of the  failure  of abnormal  F1  mice  to  respond  in  vitro  to  TNP-KLH  was 
investigated by assaying the ability of purified populations of accessory cells, T  cells, 
and  B cells from these mice to function in responses to TNP-KLH. The results of 
these experiments demonstrated that helper T  cells and antigen-presenting accessory 
cells from abnormal Fa mice were competent and functioned as well as the equivalent H. S.  BOSWELL, M.  I. NERENBERG, I. SCHER, AND A. SINGER  1207 
cell populations from normal F1 mice, Instead, the failure of CBA/N mice to generate 
primary in vitro responses to TNP-KLH was solely the result of a defect in their B cell 
population  such  that  B  cells  from these  mice failed  to  be triggered  by competent 
helper T  cells and/or competent accessory cells. 
Similarly, the failure of abnormal Fx mice to respond either in vivo or in vitro to 
TNP-Ficoll was not the result of defective accessory cell presentation of TNP-Ficoll, 
but was the result of the failure of B cells from these mice to be activated by competent 
TNP-Ficoll-presenting accessory cells, 
In contrast to the failure of B cells from abnormal F1 mice to be activated in vitro 
in response to either TNP-KLH or TNP-Ficoll, B cells from abnormal F~ mice were 
triggered  to  respond  to  TNP-BA  and  TNP-LPS,  antigens  that  did  not  require 
accessory cell presentation. The specific failure of B cells from abnormal Fa mice to be 
activated in responses that required antlgen-presentation by accessory cells suggested 
the possibility that the X-linked CBA/N genetic defect resulted in B cell populations 
that might be deficient in their ability to interact with antigen-presenting accessory 
cells. To further explore this possibility, accessory cells were pulsed with TNP-BA (an 
antigen to which B cells from abnormal Ft mice responded) and added to culture as 
TNP-BA-presenting cells.  Although  B  cells  from abnormal  F:  mice were triggered 
and responded to TNP-BA free in suspension, the same abnormal B cell populations 
failed to be triggered by TNP-BA presented by pulsed accessory cells. 
The results of these experiments suggest that the B cell populations that abnormal 
CBA/N mice possess fail to be triggered by their interaction with antigen-presenting 
accessory cells,  regardless of the  antigen  being  presented.  Indeed,  it  is  possible to 
explain many of the immune abnormalities observed in CBA/N mice as the result of 
a  single interaction defect between antigen-presenting accessory cells and CBA/N B 
cells. 
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